Nuvectis Pharma, Inc.: shareholders and insiders

NVCTNASDAQHealthcare · Pharmaceutical Preparations

Price

$19.39

November 20, 2026Market cap $667M

What Ploutos Investor adds for Nuvectis Pharma

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 5 fiscal years, from 2021
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 22, 2025 to Aug 5, 2026, from their own Form 4 filings.

7 Form 4s

Bought on the market

$1.2M

2 people

Sold on the market

–

nobody

From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $1.2M by 2 people·no sales

  • 2025: no buys, no sales
  • 2026: bought $1.2M by 2 people, no sales
  • Aug 3, 2026Michael J. CarsonVice President, Finance
    Kind
  • Jun 30, 2026Marlio Charles Mosseri
    Kind
  • Jun 30, 2026Ron BentsurChairman & CEO
    Kind
  • Jun 11, 2026Kenneth HobermanDirector
    Kind
  • Jun 11, 2026James F Oliviero IIIDirector
    Kind
  • Jun 11, 2026Juan SanchezDirector
    Kind
  • Jun 11, 2026Matthew L. KaplanDirector
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by NVCT's officers and directors from 2022 up to November 21, 2025, 4 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

1 Holders over 5%Aug 6, 2026 Latest filing
  • Soleus Private Equity Fund III, L.P.with 8 more persons
    Share of class5.10%

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter-62%
  • AQR Capital
    In the quarter+0.8%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 6.98% of its shares outstanding were held short, -4.8% since the report before.

Shares held short
2.40M
6.98%
Since the report before2.52M on Sep 30, 2026
-4.8%
13.9
172.4K
More days to cover thanof 4,578 US-listed companies with enough volume
97%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 290.9K
  • Nov 15, 2023: Shares held short 345.5K
  • Nov 30, 2023: Shares held short 348.4K
  • Dec 15, 2023: Shares held short 338.8K
  • Dec 29, 2023: Shares held short 362.7K
  • Jan 12, 2024: Shares held short 400.6K
  • Jan 31, 2024: Shares held short 503.4K
  • Feb 15, 2024: Shares held short 602.2K
  • Feb 29, 2024: Shares held short 723.6K
  • Mar 15, 2024: Shares held short 766.1K
  • Mar 28, 2024: Shares held short 808.2K
  • Apr 15, 2024: Shares held short 822.6K
  • Apr 30, 2024: Shares held short 944.0K
  • May 15, 2024: Shares held short 1.02M
  • May 31, 2024: Shares held short 1.17M
  • Jun 14, 2024: Shares held short 1.15M
  • Jun 28, 2024: Shares held short 1.08M
  • Jul 15, 2024: Shares held short 884.2K
  • Jul 31, 2024: Shares held short 841.2K
  • Aug 15, 2024: Shares held short 902.5K
  • Aug 30, 2024: Shares held short 924.4K
  • Sep 13, 2024: Shares held short 977.0K
  • Sep 30, 2024: Shares held short 989.6K
  • Oct 15, 2024: Shares held short 1.05M
  • Oct 31, 2024: Shares held short 1.13M
  • Nov 15, 2024: Shares held short 1.39M
  • Nov 29, 2024: Shares held short 1.42M
  • Dec 13, 2024: Shares held short 1.44M
  • Dec 31, 2024: Shares held short 1.42M
  • Jan 15, 2025: Shares held short 1.48M
  • Jan 31, 2025: Shares held short 1.48M
  • Feb 14, 2025: Shares held short 1.56M
  • Feb 28, 2025: Shares held short 1.34M
  • Mar 14, 2025: Shares held short 1.49M
  • Mar 31, 2025: Shares held short 1.63M
  • Apr 15, 2025: Shares held short 1.63M
  • Apr 30, 2025: Shares held short 1.89M
  • May 15, 2025: Shares held short 2.10M
  • May 30, 2025: Shares held short 2.11M
  • Jun 13, 2025: Shares held short 2.12M
  • Jun 30, 2025: Shares held short 2.64M
  • Jul 15, 2025: Shares held short 2.64M
  • Jul 31, 2025: Shares held short 1.06M
  • Aug 15, 2025: Shares held short 1.02M
  • Aug 29, 2025: Shares held short 982.8K
  • Sep 15, 2025: Shares held short 854.6K
  • Sep 30, 2025: Shares held short 987.7K
  • Oct 15, 2025: Shares held short 900.8K
  • Oct 31, 2025: Shares held short 1.23M
  • Nov 14, 2025: Shares held short 1.33M
  • Nov 28, 2025: Shares held short 1.37M
  • Dec 15, 2025: Shares held short 1.43M
  • Dec 31, 2025: Shares held short 1.53M
  • Jan 15, 2026: Shares held short 1.62M
  • Jan 30, 2026: Shares held short 1.59M
  • Feb 13, 2026: Shares held short 1.65M
  • Feb 27, 2026: Shares held short 1.62M
  • Mar 13, 2026: Shares held short 1.62M
  • Mar 31, 2026: Shares held short 1.58M
  • Apr 15, 2026: Shares held short 1.54M
  • Apr 30, 2026: Shares held short 1.46M
  • May 15, 2026: Shares held short 1.43M
  • May 29, 2026: Shares held short 1.58M
  • Jun 15, 2026: Shares held short 1.57M
  • Jun 30, 2026: Shares held short 1.80M
  • Jul 15, 2026: Shares held short 1.51M
  • Jul 31, 2026: Shares held short 1.84M
  • Aug 14, 2026: Shares held short 1.84M
  • Aug 31, 2026: Shares held short 2.20M
  • Sep 15, 2026: Shares held short 2.36M
  • Sep 30, 2026: Shares held short 2.52M
  • Oct 15, 2026: Shares held short 2.40M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading64.7% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 64.7% of the shares in the reported trades were short sales, against 69.0% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
64.7%
The 14 beforeOct 14, 2026 – Nov 2, 2026
69.0%
Change
-4.3 pts
Short sales a dayon average, of 87.6K shares
56.7K
More than atof 3,666 US-listed companies, same days
91%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 57.2%
  • Oct 15, 2026: Short sales 82.7%
  • Oct 16, 2026: Short sales 74.8%
  • Oct 19, 2026: Short sales 60.7%
  • Oct 20, 2026: Short sales 73.6%
  • Oct 21, 2026: Short sales 71.3%
  • Oct 22, 2026: Short sales 83.2%
  • Oct 23, 2026: Short sales 79.2%
  • Oct 26, 2026: Short sales 81.5%
  • Oct 27, 2026: Short sales 68.1%
  • Oct 28, 2026: Short sales 59%
  • Oct 29, 2026: Short sales 51%
  • Oct 30, 2026: Short sales 58.1%
  • Nov 2, 2026: Short sales 67.4%
  • Nov 3, 2026: Short sales 71.7%
  • Nov 4, 2026: Short sales 71.9%
  • Nov 5, 2026: Short sales 42.9%
  • Nov 6, 2026: Short sales 60.9%
  • Nov 9, 2026: Short sales 65.6%
  • Nov 10, 2026: Short sales 47.9%
  • Nov 11, 2026: Short sales 55.4%
  • Nov 12, 2026: Short sales 49.3%
  • Nov 13, 2026: Short sales 69.1%
  • Nov 16, 2026: Short sales 72.3%
  • Nov 17, 2026: Short sales 83.2%
  • Nov 18, 2026: Short sales 82.5%
  • Nov 19, 2026: Short sales 84.2%
  • Nov 20, 2026: Short sales 62.3%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

13.28M Insiders' shares50.13% Of the company
  • Marlio Charles MosseriTenPercentOwner
    Directly2.61M
  • Ron BentsurChairman & CEO
    Directly3.69M
  • Enrique PoradosuChief Science & Business Off
    Directly1.51M
  • Shay ShemeshChief Dev. & Ops. Officer
    Directly1.49M
  • Michael J. CarsonVice President, Finance
    Directly230.1K
  • Kenneth HobermanDirector
    Directly168.1K
  • Matthew L. KaplanDirector
    Directly159.8K
  • James F Oliviero IIIDirector
    Directly122.8K
  • Juan SanchezDirector
    Directly113.8K

A lower bound: it counts only the 9 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

6 ETFs holding it0.07% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.07%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.02%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.01%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

6 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

83 Managers, Q2 2026$190M Value of their positions
  • Q3 2025: Managers 53
  • Q4 2025: Managers 48
  • Q1 2026: Managers 62
  • Q2 2026: Managers 83

Institutional investors by quarter

The fund managers holding NVCT, quarter by quarter, from Q1 2022 to Q2 2025, 14 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 83 managers held 10.28M shares, worth $190M. During the quarter 29 opened a position, 8 closed one, 32 added and 11 trimmed.

The largest holders, Q2 2026

  • Tang Capital Management
    In the quarter
  • BlackRock
    In the quarter+31%
  • Soleus Capital Management
    In the quarter
  • Perceptive Advisors
    In the quarter
  • Vanguard Capital Management
    In the quarter+32%
  • Iridian Asset Management
    In the quarter+19%
  • Geode Capital Management
    In the quarter+13%
  • Sphera Funds Management
    In the quarter
  • Baldwin Wealth Partners
    In the quarter+0.9%
  • Occam Crest Management
    In the quarter-12%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Nuvectis Pharma's filings show?

Who buys and sells is one part of Nuvectis Pharma's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about NVCT's shareholders

Didn't find what you were looking for?

Ask us
Have NVCT's insiders bought or sold?

From Jun 12, 2026 to Aug 5, 2026 Nuvectis Pharma's insiders bought $1.2M and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.

Which well-known managers hold NVCT?

3 of the managers we track held the shares on Sep 30, 2026. The largest position was Point72 (Cohen)'s, worth $1.0M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.